@article{5191e500aff74e62947437a67c43388a,
title = "Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial",
author = "Polkinghorne, {Kevan R.} and Wetmore, {James B.} and Thao, {Le Thi Phuong} and Rory Wolfe and Woods, {Robyn L.} and Ernst, {Michael E.} and Nelson, {Mark R.} and Reid, {Christopher M.} and Shah, {Raj C.} and McNeil, {John J.} and Murray, {Anne M.}",
note = "Funding Information: ASPREE was supported by the National Institutes of Health National Institute on Aging (NIH NIA) and the National Cancer Institute (U01AG029824); the National Health and Medical Research Council (NHMRC) of Australia (334047, 1127060); and Monash University and the Victorian Cancer Agency. This work was supported by the aforementioned funders, plus NIH NIA grant U19AG062682. CMR is supported through an NHMRC Principal Research Fellowship (APP136372). The funders of this study had no role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. Funding Information: Conceived the research questions and designed the study: KRP, RW, JBW, LTPT, RLW, JJM, AMM; involved in acquisition and interpretation of data: KRP, RW, JBW, LTPT, RLW, MEE, MRN, CMR, RCS, JJM, AMM; analyzed the data: KRP, LTPT, RW. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for the individual's own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate. ASPREE was supported by the National Institutes of Health National Institute on Aging (NIH NIA) and the National Cancer Institute (U01AG029824); the National Health and Medical Research Council (NHMRC) of Australia (334047, 1127060); and Monash University and the Victorian Cancer Agency. This work was supported by the aforementioned funders, plus NIH NIA grant U19AG062682. CMR is supported through an NHMRC Principal Research Fellowship (APP136372). The funders of this study had no role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. The authors declare that they have no other relevant financial interests. We thank the trial staff in Australia and the United States, the participants who volunteered for this trial, and the general practitioners and staff of the medical clinics who cared for the participants. Received October 1, 2021. Evaluated by 2 external peer reviewers, with direct editorial input from a Statistics/Methods Editor, an Associate Editor, and the Editor-in-Chief. Accepted in revised form February 10, 2022.",
year = "2022",
month = dec,
doi = "10.1053/j.ajkd.2022.02.019",
language = "English",
volume = "80",
pages = "810--813",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "Elsevier",
number = "6",
}